Coronavirus disease 2019: A tissue engineering and regenerative medicine perspective
Concise Review
[키워드] acute respiratory distress
acute respiratory distress syndrome
antiviral agent
Antiviral agents
ARDS
biomaterial
caused
cell processing
clinical trial
clinical trials
conducted
Coronavirus infections
COVID‐19
current
death
derivative
described
disease
Disease progression
driving
Effect
effective
Efficacy
evaluate
Exosomes
Impact
infective
Inflammation
Last
majority
medical need
mesenchymal stem cell
MSC
MSC therapy
MSCs
novel coronavirus disease
pandemic
Perspective
platform
progression
regenerative
required
Research
Safe
stem cell
syndrome
the disease
Therapeutic benefit
Therapies
therapy
tissue
Treatment
Vaccine
[DOI] 10.1002/sctm.20-0197 PMC 바로가기 [Article Type] Concise Review
[DOI] 10.1002/sctm.20-0197 PMC 바로가기 [Article Type] Concise Review